These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10771723)

  • 1. [Risk assessment concerning hospital personnel participating in the preparation and administration of antineoplastic drugs].
    Minoia C; Turci R; Sottani C; Schiavi A; Perbellini L; Angeleri S; Frigerio F; Draicchio F; Apostoli P
    G Ital Med Lav Ergon; 1999; 21(2):93-107. PubMed ID: 10771723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide.
    Minoia C; Turci R; Sottani C; Schiavi A; Perbellini L; Angeleri S; Draicchio F; Apostoli P
    Rapid Commun Mass Spectrom; 1998; 12(20):1485-93. PubMed ID: 9796535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals.
    Acampora A; Castiglia L; Miraglia N; Pieri M; Soave C; Liotti F; Sannolo N
    Ann Occup Hyg; 2005 Oct; 49(7):611-8. PubMed ID: 15964876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation.
    Sessink PJ; Leclercq GM; Wouters DM; Halbardier L; Hammad C; Kassoul N
    J Oncol Pharm Pract; 2015 Apr; 21(2):118-27. PubMed ID: 24567041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid-liquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry.
    Sottani C; Turci R; Perbellini L; Minoia C
    Rapid Commun Mass Spectrom; 1998; 12(16):1063-8. PubMed ID: 9737012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly sensitive high-performance liquid chromatography/selective reaction monitoring mass spectrometry method for the determination of cyclophosphamide and ifosfamide in urine of health care workers exposed to antineoplastic agents.
    Sottani C; Tranfo G; Faranda P; Minoia C
    Rapid Commun Mass Spectrom; 2005; 19(19):2794-800. PubMed ID: 16144038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
    Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP
    Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambient monitoring of cyclophosphamide in manufacture and hospitals.
    Pyy L; Sorsa M; Hakala E
    Am Ind Hyg Assoc J; 1988 Jun; 49(6):314-7. PubMed ID: 3400596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces.
    Hedmer M; Jönsson BA; Nygren O
    J Environ Monit; 2004 Dec; 6(12):979-84. PubMed ID: 15568047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden.
    Hedmer M; Georgiadi A; Bremberg ER; Jönsson BA; Eksborg S
    Ann Occup Hyg; 2005 Oct; 49(7):629-37. PubMed ID: 16126760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Headache as "sentinel" symptom in personnel involved in the preparation and administration of antineoplastic drugs].
    Pucci E; Matozzo F; Luppi P; Micoli G; Sottani C; Minoia C; Sandrini G; Nappi G
    G Ital Med Lav Ergon; 2005; 27(4):412-6. PubMed ID: 16512337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry: bioanalytical method validation.
    Sottani C; Rinaldi P; Leoni E; Poggi G; Teragni C; Delmonte A; Minoia C
    Rapid Commun Mass Spectrom; 2008 Sep; 22(17):2645-59. PubMed ID: 18666202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiblastic drug exposure: statistical analysis of the data coming from environmental monitoring of a site devoted to drug production].
    Miraglia N; Castiglia L; Muselli A; Astarita S; Acampora A; Sannolo N
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):739-40. PubMed ID: 18409934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations.
    Pethran A; Schierl R; Hauff K; Grimm CH; Boos KS; Nowak D
    Int Arch Occup Environ Health; 2003 Feb; 76(1):5-10. PubMed ID: 12592576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators.
    Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D
    Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings.
    Sabatini L; Barbieri A; Lodi V; Violante FS
    Med Lav; 2012; 103(5):394-401. PubMed ID: 23077799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents.
    Wick C; Slawson MH; Jorgenson JA; Tyler LS
    Am J Health Syst Pharm; 2003 Nov; 60(22):2314-20. PubMed ID: 14652980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents.
    Turci R; Sottani C; Ronchi A; Minoia C
    Toxicol Lett; 2002 Aug; 134(1-3):57-64. PubMed ID: 12191861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure of hospital pharmacists and nurses to antineoplastic agents.
    McDevitt JJ; Lees PS; McDiarmid MA
    J Occup Med; 1993 Jan; 35(1):57-60. PubMed ID: 8423505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.